Protara Therapeutics, Inc. Royalty Expense
Protara Therapeutics, Inc. (TARA) reported Royalty Expense of $0 for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2015-11-12
- Protara Therapeutics, Inc. royalty expense for the quarter ending 2015-09-30 was $0.00.
- Protara Therapeutics, Inc. royalty expense for the quarter ending 2015-06-30 was $0.00.
- Protara Therapeutics, Inc. royalty expense for the quarter ending 2015-03-31 was $0.00.
| Period end | Royalty Expense 3 month | Royalty Expense 6 month | Royalty Expense 9 month |
|---|---|---|---|
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 derived: sum of 2 quarters · filed 2015-11-12 | $0.00 10-Q · filed 2015-11-12 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $0.00 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |